Brief: Active Biotech Expands U.S. Collaboration
18/08/2026 09:53
BRIEF-Active Biotech Expands U.S. Collaboration Aug 18 (Reuters) - Active Biotech AB publ ACTI.ST:
ACTIVE BIOTECH: ACTIVE BIOTECH EXPANDS US COLLABORATION TO ADVANCE TASQUINIMOD CLINICAL DEVELOPMENT IN MYELOFIBROSIS
Source text: ID:nMFN63zBGH
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million